Keywords
Last Name
Institution

Douglas Jabs

TitleDEAN FOR CLINICAL AFFAIRS
InstitutionMount Sinai
Address17 East 102nd Street
8th Floor-West
New York NY 10029
Phone212-241-0939
Fax212-824-2325
    Other Positions
    TitlePROFESSOR & CHAIR
    InstitutionMount Sinai
    DepartmentOphthalmology

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentMedicine


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Branch AD, Drye LT, Van Natta ML, Sezgin E, Fishman SL, Dieterich DT, Meinert CL, Jabs DA. Evaluation of Hepatitis C Virus as a Risk Factor for HIV-Associated Neuroretinal Disorder. Clin Infect Dis. 2013 Dec; 57(11):1618-25.
      View in: PubMed
    2. Krauskopf K, Van Natta ML, Danis RP, Gangaputra S, Ackatz L, Addessi A, Federman AD, Branch AD, Meinert CL, Jabs DA. Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy. J Int Assoc Provid AIDS Care. 2013 Sep-Oct; 12(5):325-33.
      View in: PubMed
    3. Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Response of pediatric uveitis to tumor necrosis factor-a inhibitors. J Rheumatol. 2013 Aug; 40(8):1394-403.
      View in: PubMed
    4. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep; 156(3):468-77.e2.
      View in: PubMed
    5. Okada AA, Jabs DA. The standardization of uveitis nomenclature project: the future is here. JAMA Ophthalmol. 2013 Jun; 131(6):787-9.
      View in: PubMed
    6. Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013 Aug; 156(2):228-36.
      View in: PubMed
    7. Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2013 Jun; 120(6):1262-70.
      View in: PubMed
    8. Trusko B, Thorne J, Jabs D, Belfort R, Dick A, Gangaputra S, Nussenblatt R, Okada A, Rosenbaum J. The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013 May 7; 52(3):259-65, S1-6.
      View in: PubMed
    9. Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2013 Feb; 155(2):206-212.e5.
      View in: PubMed
    10. Gregory AC, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013 Jan; 120(1):186-92.
      View in: PubMed
    11. Jabs DA. Regional corticosteroids for scleritis. Ophthalmology. 2012 Oct; 119(10):2198-2199.e1; author reply 2199-200.
      View in: PubMed
    12. Lehpamer B, Moshier E, Goldberg N, Ackert J, Godbold J, Jabs DA. Subretinal fluid in uveitic macular edema: effect on vision and response to therapy. Am J Ophthalmol. 2013 Jan; 155(1):143-9.
      View in: PubMed
    13. Kempen JH, Sugar EA, Lyon AT, Lewis RA, Jabs DA, Heinemann MH, Dunn JP. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 2012 Nov; 119(11):2343-50.
      View in: PubMed
    14. Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Risk of hypotony in noninfectious uveitis. Ophthalmology. 2012 Nov; 119(11):2377-85.
      View in: PubMed
    15. Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, Kozak I, Holbrook JT, Jabs DA, Kempen JH. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm. 2012 Jun; 20(3):171-81.
      View in: PubMed
    16. Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis. 2012 Jul; 55(1):137-44.
      View in: PubMed
    17. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012 Aug; 119(8):1569-74.
      View in: PubMed
    18. Smith JR, Jabs DA, Van Gelder RN. Uveitis is a subspeciality. Ophthalmology. 2012 Apr; 119(4):887-8; author reply 888.
      View in: PubMed
    19. Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH. High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocul Immunol Inflamm. 2012 Apr; 20(2):91-9.
      View in: PubMed
    20. Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA. Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012 Apr; 20(2):104-12.
      View in: PubMed
    21. Limou S, Delaneau O, van Manen D, An P, Sezgin E, Le Clerc S, Coulonges C, Troyer JL, Veldink JH, van den Berg LH, Spadoni JL, Taing L, Labib T, Montes M, Delfraissy JF, Schachter F, O'Brien SJ, Buchbinder S, van Natta ML, Jabs DA, Froguel P, Schuitemaker H, Winkler CA, Zagury JF. Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. J Infect Dis. 2012 Apr 1; 205(7):1155-62.
      View in: PubMed
    22. Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012 Jun; 153(6):1016-24.e5.
      View in: PubMed
    23. Holbrook JT, Kempen JH, Prusakowski NA, Altaweel MM, Jabs DA. Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials. Clin Trials. 2011 Dec; 8(6):736-43.
      View in: PubMed
    24. Sugar EA, Jabs DA, Altaweel MM, Lightman S, Acharya N, Vitale AT, Thorne JE. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol. 2011 Dec; 152(6):1044-1052.e5.
      View in: PubMed
    25. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011 Oct; 118(10):1916-26.
      View in: PubMed
    26. Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol. 2011 Oct; 152(4):628-637.e1.
      View in: PubMed
    27. Grunwald L, Newcomb CW, Daniel E, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Risk of relapse in primary acute anterior uveitis. Ophthalmology. 2011 Oct; 118(10):1911-5.
      View in: PubMed
    28. Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol. 2011 Sep; 152(3):441-448.e2.
      View in: PubMed
    29. Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA. Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol. 2011 Jun; 151(6):999-1006.e4.
      View in: PubMed
    30. Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011 Feb; 151(2):198-216.e1.
      View in: PubMed
    31. Thorne JE, Van Natta ML, Jabs DA, Duncan JL, Srivastava SK. Visual field loss in patients with cytomegalovirus retinitis. Ophthalmology. 2011 May; 118(5):895-901.
      View in: PubMed
    32. Forooghian F, Gulati N, Jabs DA. Restoration of retinal architecture following systemic immunosuppression in birdshot chorioretinopathy. Ocul Immunol Inflamm. 2010 Dec; 18(6):470-1.
      View in: PubMed
    33. Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O'Brien SJ. Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis. 2010 Aug 15; 202(4):606-13.
      View in: PubMed
    34. Sezgin E, Hendrickson SL, Jabs DA, Van Natta ML, Lewis RA, Troyer JL, O'Brien SJ. Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS. J Acquir Immune Defic Syndr. 2010 Aug; 54(4):343-51.
      View in: PubMed
    35. Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology. 2010 Nov; 117(11):2152-61.e1-2.
      View in: PubMed
    36. Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol. 2010 Jul; 94(7):848-53.
      View in: PubMed
    37. Gulati N, Forooghian F, Lieberman R, Jabs DA. Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2011 Feb; 95(2):162-5.
      View in: PubMed
    38. Holland GN, Kappel PJ, Van Natta ML, Palella FJ, Lyon AT, Shah KH, Pavan PR, Jabs DA. Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome. Am J Ophthalmol. 2010 May; 149(5):807-16.
      View in: PubMed
    39. Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010 Jul; 117(7):1436-41.
      View in: PubMed
    40. Hendrickson SL, Jabs DA, Van Natta M, Lewis RA, Wallace DC, O'Brien SJ. Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients. J Acquir Immune Defic Syndr. 2010 Apr 1; 53(4):451-5.
      View in: PubMed
    41. Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am J Ophthalmol. 2010 Feb; 149(2):189-193.e2.
      View in: PubMed
    42. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010 Apr; 149(4):550-561.e10.
      View in: PubMed
    43. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010 Mar; 117(3):576-84.
      View in: PubMed
    44. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar; 149(3):423-32.e1-2.
      View in: PubMed
    45. Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Hypopyon in patients with uveitis. Ophthalmology. 2010 Feb; 117(2):366-72.
      View in: PubMed
    46. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010 Feb; 117(2):356-65.
      View in: PubMed
    47. Jabs DA, Martin BK, Forman MS. Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS. Ophthalmology. 2010 Jan; 117(1):128-132.e2.
      View in: PubMed
    48. Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009 Nov; 116(11):2188-98.e1.
      View in: PubMed
    49. Galor A, Davis JL, Flynn HW, Feuer WJ, Dubovy SR, Setlur V, Kesen MR, Goldstein DA, Tessler HH, Ganelis IB, Jabs DA, Thorne JE. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol. 2009 Nov; 148(5):704-710.e2.
      View in: PubMed
    50. Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009; 339:b2480.
      View in: PubMed
    51. Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009 Oct; 148(4):500-509.e2.
      View in: PubMed
    52. Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials. 2009 May-Jun; 10(3):143-52.
      View in: PubMed
    53. Bélair ML, Kim SJ, Thorne JE, Dunn JP, Kedhar SR, Brown DM, Jabs DA. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009 Jul; 148(1):128-35.e2.
      View in: PubMed
    54. Smith JR, Jabs DA, Briceland DJ, Holland GN. Education in the ophthalmic discipline of uveitis. Am J Ophthalmol. 2008 Dec; 146(6):799-801.
      View in: PubMed
    55. Thorne JE, Woreta FA, Jabs DA, Anhalt GJ. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Ophthalmology. 2008 Dec; 115(12):2146-2152.e1.
      View in: PubMed
    56. Jabs DA. Epidemiology of uveitis. Ophthalmic Epidemiol. 2008 Sep-Oct; 15(5):283-4.
      View in: PubMed
    57. Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008 Dec; 146(6):828-36.
      View in: PubMed
    58. Jabs DA. AIDS and ophthalmology, 2008. Arch Ophthalmol. 2008 Aug; 126(8):1143-6.
      View in: PubMed
    59. Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer KJ. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol. 2008 Dec; 146(6):802-12.e1.
      View in: PubMed
    60. Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology. 2008 Oct; 115(10):1826-32.
      View in: PubMed
    61. Kim SJ, Belair ML, Bressler NM, Dunn JP, Thorne JE, Kedhar SR, Jabs DA. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina. 2008 Jun; 28(6):870-6.
      View in: PubMed
    62. Kim SJ, Adams NA, Toma HS, Belair ML, Thorne JE, Green WR, Jabs DA. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study. Retina. 2008 Apr; 28(4):595-605.
      View in: PubMed
    63. Thorne JE, Daniel E, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol. 2008 May; 145(5):841-6.
      View in: PubMed
    64. Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, Sinclair E. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis. 2008 Feb 1; 46(3):458-66.
      View in: PubMed
    65. Leder HA, Galor A, Thorne JE, Jabs D. Disappearance of classic birdshot spots after immunosuppression with tacrolimus and mycophenolate mofetil. Br J Ophthalmol. 2008 Feb; 92(2):291.
      View in: PubMed
    66. Freeman WR, Van Natta ML, Jabs D, Sample PA, Sadun AA, Thorne J, Shah KH, Holland GN. Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol. 2008 Mar; 145(3):453-462.
      View in: PubMed
    67. Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. 2008 Jan-Feb; 15(1):47-55.
      View in: PubMed
    68. Kedhar SR, Jabs DA. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Herpes. 2007 Dec; 14(3):66-71.
      View in: PubMed
    69. Jabs DA, Prendergast RA, Campbell AL, Lee B, Akpek EK, Gérard HC, Hudson AP, Whittum-Hudson JA. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5624-9.
      View in: PubMed
    70. Thorne JE, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol. 2008 Jan; 145(1):23-28.
      View in: PubMed
    71. Kedhar SR, Thorne JE, Wittenberg S, Dunn JP, Jabs DA. Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina. 2007 Nov-Dec; 27(9):1174-9.
      View in: PubMed
    72. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2007 Sep; 114(9):1713-21.
      View in: PubMed
    73. Galor A, Thorne JE, Jabs DA. Rheumatic disease and scleritis. Ophthalmology. 2007 Jun; 114(6):1232.
      View in: PubMed
    74. Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology. 2007 Jun; 114(6):1201-4.
      View in: PubMed
    75. Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007 May; 143(5):840-846.
      View in: PubMed
    76. Martin BK, Ricks MO, Forman MS, Jabs DA. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin Infect Dis. 2007 Apr 1; 44(7):1001-8.
      View in: PubMed
    77. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007 Apr; 114(4):780-6.
      View in: PubMed
    78. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007 Apr; 114(4):787-93.
      View in: PubMed
    79. Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007 Apr; 143(4):647-55.
      View in: PubMed
    80. Thorne JE, Wittenberg S, Kedhar SR, Dunn JP, Jabs DA. Optic neuropathy complicating multifocal choroiditis and panuveitis. Am J Ophthalmol. 2007 Apr; 143(4):721-3.
      View in: PubMed
    81. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 2007 Mar; 114(3):591-8.
      View in: PubMed
    82. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. J Infect Dis. 2006 Dec 1; 194(11):1537-46.
      View in: PubMed
    83. Brown DM, Thorne JE, Foster GL, Duncan JL, Brune LM, Muñana A, Meinert CL, Jabs DA. Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care. 2006 Oct; 18(7):821-9.
      View in: PubMed
    84. Thorne JE, Wittenberg S, Jabs DA, Peters GB, Reed TL, Kedhar SR, Dunn JP. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology. 2006 Dec; 113(12):2310-6.
      View in: PubMed
    85. Daniel E, Gangaputra S, Kempen JH, Jabs DA. Recurrent nodular scleritis preceding an adult TINU syndrome. Ocul Immunol Inflamm. 2006 Aug; 14(4):239-40.
      View in: PubMed
    86. Thorne JE, Anhalt GJ, Jabs DA, de la Cruz Z, Green WR. Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid. Ophthalmology. 2006 Sep; 113(9):1651-6.
      View in: PubMed
    87. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006 Aug; 113(8):1441-5.
      View in: PubMed
    88. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006 Aug; 113(8):1432-40.
      View in: PubMed
    89. Jabs DA, Martin BK, Ricks MO, Forman MS. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis. 2006 Jun 15; 193(12):1728-37.
      View in: PubMed
    90. Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
      View in: PubMed
    91. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol. 2005 Oct; 140(4):674-8.
      View in: PubMed
    92. Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina. 2005 Sep; 25(6):759-66.
      View in: PubMed
    93. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep; 140(3):509-16.
      View in: PubMed
    94. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005 Aug; 112(8):1472-7.
      View in: PubMed
    95. Jabs DA, Martin BK, Forman MS, Ricks MO. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis. 2005 Aug 15; 192(4):640-9.
      View in: PubMed
    96. Thorne JE, Jabs DA, Peters GB, Hair D, Dunn JP, Kempen JH. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005 Jul; 140(1):45-51.
      View in: PubMed
    97. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Am J Ophthalmol. 2005 Jun; 139(6):1028-34.
      View in: PubMed
    98. Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2005 May; 112(5):771-9.
      View in: PubMed
    99. Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005 May; 139(5):900-5.
      View in: PubMed
    100. Weinberg DV, Holbrook JT, Hubbard LD, Davis MD, Jabs DA, Holland GN. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005 Apr; 112(4):559-66.
      View in: PubMed
    101. Thorne JE, Shah KH, Brown DM, Holland GN, Jabs DA. Posterior intracorneal opacities in patients with HIV infection. Ocul Immunol Inflamm. 2005 Feb; 13(1):25-31.
      View in: PubMed
    102. Jabs DA, Akpek EK. Immunosuppression for posterior uveitis. Retina. 2005 Jan; 25(1):1-18.
      View in: PubMed
    103. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology. 2004 Dec; 111(12):2224-31.
      View in: PubMed
    104. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology. 2004 Dec; 111(12):2232-9.
      View in: PubMed
    105. Jabs DA. Treatment of ocular inflammation. Ocul Immunol Inflamm. 2004 Sep; 12(3):163-8.
      View in: PubMed
    106. Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004 Sep; 138(3):338-46.
      View in: PubMed
    107. Jabs DA, Gérard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci. 2004 Jul; 45(7):2293-8.
      View in: PubMed
    108. Jabs DA. AIDS and ophthalmology in 2004. Arch Ophthalmol. 2004 Jul; 122(7):1040-2.
      View in: PubMed
    109. Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004 Mar; 111(3):501-6.
      View in: PubMed
    110. Hubbard LD, Ricks MO, Martin BK, Bressler NM, Kempen JH, Dunn JP, Jabs DA. Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. Am J Ophthalmol. 2004 Mar; 137(3):426-34.
      View in: PubMed
    111. Dunn JP, Van Natta M, Foster G, Kuppermann BD, Martin DF, Zong A, Jabs DA. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina. 2004 Feb; 24(1):41-50.
      View in: PubMed
    112. Thorne JE, Anhalt GJ, Jabs DA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004 Jan; 111(1):45-52.
      View in: PubMed
    113. Akpek EK, Jabs DA, Gérard HC, Prendergast RA, Hudson AP, Lee B, Whittum-Hudson JA. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2004 Jan; 45(1):185-90.
      View in: PubMed
    114. Tanna AP, Kempen JH, Dunn JP, Haller JA, Jabs DA. Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. Am J Ophthalmol. 2003 Dec; 136(6):1009-15.
      View in: PubMed
    115. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis. 2003 Nov 15; 37(10):1365-73.
      View in: PubMed
    116. Qazi FA, Thorne JE, Jabs DA. Scleral nodule associated with sarcoidosis. Am J Ophthalmol. 2003 Oct; 136(4):752-4.
      View in: PubMed
    117. Thorne JE, Jabs DA, Nikolskaia OV, Mimouni D, Anhalt GJ, Nousari HC. Lichen planus and cicatrizing conjunctivitis: characterization of five cases. Am J Ophthalmol. 2003 Aug; 136(2):239-43.
      View in: PubMed
    118. Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2003 May; 110(5):987-95.
      View in: PubMed
    119. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. 2003 Apr; 121(4):466-76.
      View in: PubMed
    120. Weinberg A, Jabs DA, Chou S, Martin BK, Lurain NS, Forman MS, Crumpacker C. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis. 2003 Mar 1; 187(5):777-84.
      View in: PubMed
    121. Gilpin AM, Holbrook JT, Jabs DA, Meinert CL. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Control Clin Trials. 2003 Feb; 24(1):92-8.
      View in: PubMed
    122. Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol. 2003 Jan; 135(1):26-34.
      View in: PubMed
    123. Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol. 2003 Jan; 121(1):99-107.
      View in: PubMed
    124. Latkany PA, Jabs DA, Smith JR, Rosenbaum JT, Tessler H, Schwab IR, Walton RC, Thorne JE, Maguire AM. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol. 2002 Dec; 134(6):897-904.
      View in: PubMed
    125. Thorne JE, Jabs DA, Nikolskaia O, Anhalt G, Nousari HC. Discoid lupus erythematosus and cicatrizing conjunctivitis: clinicopathologic study of two cases. Ocul Immunol Inflamm. 2002 Dec; 10(4):287-92.
      View in: PubMed
    126. Davidson M, Min YI, Holbrook JT, Van Natta M, Quinn TC, Murphy RL, Welch W, Jabs DA, Meinert CL. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. J Infect Dis. 2002 Oct 1; 186(7):1013-8.
      View in: PubMed
    127. Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002 Aug; 109(8):1506-13.
      View in: PubMed
    128. Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS. 2002 Apr 12; 16(6):877-87.
      View in: PubMed
    129. Jabs DA, Griffiths PD. Fomivirsen for the treatment of cytomegalovirus retinitis. Am J Ophthalmol. 2002 Apr; 133(4):552-6.
      View in: PubMed
    130. Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. AIDS. 2002 Mar 29; 16(5):757-65.
      View in: PubMed
    131. Hu H, Jabs DA, Forman MS, Martin BK, Dunn JP, Weinberg DV, Davis JL. Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis. J Infect Dis. 2002 Apr 1; 185(7):861-7.
      View in: PubMed
    132. Jabs DA, Prendergast RA, Whittum-Hudson JA. Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice. Adv Exp Med Biol. 2002; 506(Pt B):771-6.
      View in: PubMed
    133. Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002 Jan; 133(1):48-61.
      View in: PubMed
    134. Thorne JE, Jabs DA. Ocular manifestations of vasculitis. Rheum Dis Clin North Am. 2001 Nov; 27(4):761-79, vi.
      View in: PubMed
    135. Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F, Hu H. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Am J Ophthalmol. 2001 Nov; 132(5):700-10.
      View in: PubMed
    136. Jabs DA, Prendergast RA, Rorer EM, Hudson AP, Whittum-Hudson JA. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001 Oct; 42(11):2567-71.
      View in: PubMed
    137. Jabs DA. Sjögren's syndrome: challenges to management. Am J Manag Care. 2001 Sep; 7(14 Suppl):S431-2.
      View in: PubMed
    138. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001 Jun; 45(3):252-7.
      View in: PubMed
    139. Jabs DA, Rosenbaum JT. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2001 May; 131(5):679.
      View in: PubMed
    140. Martin BK, Kaplan Gilpin AM, Jabs DA, Wu AW. Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol. 2001 Apr; 54(4):376-86.
      View in: PubMed
    141. Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. Arch Ophthalmol. 2001 Apr; 119(4):554-63.
      View in: PubMed
    142. Jabs DA. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS. Br J Ophthalmol. 2001 Apr; 85(4):381-2.
      View in: PubMed
    143. Holbrook JT, Meinert CL, Jabs DA. Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis. Control Clin Trials. 2001 Feb; 22(1):62-8.
      View in: PubMed
    144. Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001 Feb; 42(2):399-401.
      View in: PubMed
    145. Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001 Jan; 119(1):33-40.
      View in: PubMed
    146. Kempen JH, Frick KD, Jabs DA. Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS. Pharmacoeconomics. 2001; 19(12):1199-208.
      View in: PubMed
    147. Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis. 2001 Jan 15; 183(2):333-337.
      View in: PubMed
    148. Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000 Oct; 130(4):469-76.
      View in: PubMed
    149. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000 Oct; 130(4):492-513.
      View in: PubMed
    150. Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Arch Ophthalmol. 2000 Sep; 118(9):1196-204.
      View in: PubMed
    151. Farr AK, Jabs DA, Green WR. Optic disc sarcoid granuloma. Arch Ophthalmol. 2000 May; 118(5):728-9.
      View in: PubMed
    152. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000 May; 129(5):634-9.
      View in: PubMed
    153. Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci. 2000 Mar; 41(3):826-31.
      View in: PubMed
    154. Jabs DA, Forman M, Enger C, Jackson JB. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. J Clin Microbiol. 1999 May; 37(5):1431-5.
      View in: PubMed
    155. Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, Bressler NM. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999 Mar; 106(3):594-9.
      View in: PubMed
    156. Thorne JE, Jabs DA, Vitale S, Miller T, Dunn JP, Semba RD. Catheter complications in AIDS patients treated for cytomegalovirus retinitis. AIDS. 1998 Dec 3; 12(17):2321-7.
      View in: PubMed
    157. Jabs DA, Bolton SG, Dunn JP, Palestine AG. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol. 1998 Dec; 126(6):817-22.
      View in: PubMed
    158. Stone JH, Nousari HC, Jabs DA, Griffith LS. Takayansu's Arteritis Associated with Anterior Uveitis and Cutaneous Extravascular Necrotizing Granuloma. J Clin Rheumatol. 1998 Dec; 4(6):319-22.
      View in: PubMed
    159. Jabs DA, Enger C, Dunn JP, Forman M, Hubbard L. Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group. Am J Ophthalmol. 1998 Oct; 126(4):543-9.
      View in: PubMed
    160. de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 1998 Oct; 39(3):141-62.
      View in: PubMed
    161. Jabs DA, Enger C, Forman M, Dunn JP. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. Antimicrob Agents Chemother. 1998 Sep; 42(9):2240-4.
      View in: PubMed
    162. Jabs DA. The eye and rheumatic disease. Bull Rheum Dis. 1998 Aug; 47(5):5-10.
      View in: PubMed
    163. Jabs DA. Acyclovir for recurrent herpes simplex virus ocular disease. N Engl J Med. 1998 Jul 30; 339(5):340-1.
      View in: PubMed
    164. Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
      View in: PubMed
    165. Griffiths RI, Bleecker GC, Jabs DA, Dieterich DT, Coleson L, Winters D, Wolitz R, Steinberg EP. Pharmacoeconomic analysis of 3 treatment strategies for cytomegalovirus retinitis in patients with AIDS. Pharmacoeconomics. 1998 Apr; 13(4):461-74.
      View in: PubMed
    166. Jabs DA, Enger C, Dunn JP, Forman M. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. J Infect Dis. 1998 Mar; 177(3):770-3.
      View in: PubMed
    167. Jabs DA. Cytomegalovirus retinitis and the evolving AIDS epidemic. Retina. 1998; 18(5):395-8.
      View in: PubMed
    168. Jabs DA, Lee B, Prendergast RA. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice. Curr Eye Res. 1997 Sep; 16(9):909-16.
      View in: PubMed
    169. Tay-Kearney ML, Enger C, Semba RD, Royal W, Dunn JP, Jabs DA. T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients. J Infect Dis. 1997 Sep; 176(3):790-4.
      View in: PubMed
    170. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997 Aug; 124(2):227-33.
      View in: PubMed
    171. Jabs DA. Cidofovir. Arch Ophthalmol. 1997 Jun; 115(6):785-6.
      View in: PubMed
    172. Shalaby IA, Dunn JP, Semba RD, Jabs DA. Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1997 Apr; 115(4):469-73.
      View in: PubMed
    173. Mueller AJ, Jacobson MA, Hurwitz S, Chuang EL, Friedberg DN, Haidt SJ, Heinemann MH, Jabs DA, Kaplan HJ, Freeman WR. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. AIDS. 1997 Mar; 11(3):397-9.
      View in: PubMed
    174. Enger C, Jabs DA, Dunn JP, Forman MS, Bressler NM, Margolick JB, Charache P. Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research Group. Ophthalmic Epidemiol. 1997 Mar; 4(1):41-8.
      View in: PubMed
    175. Johnson DA, Jabs DA. The ocular manifestations of graft-versus-host disease. Int Ophthalmol Clin. 1997; 37(2):119-33.
      View in: PubMed
    176. van der Meer JT, Drew WL, Bowden RA, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA, Whitley RJ. Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res. 1996 Nov; 32(3):119-40.
      View in: PubMed
    177. Tay-Kearney ML, Jabs DA. Ophthalmic complications of HIV infection. Med Clin North Am. 1996 Nov; 80(6):1471-92.
      View in: PubMed
    178. Miller NR, Jabs DA, Green WR. Simultaneous, multiple cranial neuropathies in patients with diabetes mellitus. J Neuroophthalmol. 1996 Sep; 16(3):231.
      View in: PubMed
    179. Dunn JP, Noorily SW, Petri M, Finkelstein D, Rosenbaum JT, Jabs DA. Antiphospholipid antibodies and retinal vascular disease. Lupus. 1996 Aug; 5(4):313-22.
      View in: PubMed
    180. Jabs DA. Treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1996 Jul 15; 125(2):144-5.
      View in: PubMed
    181. Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Arch Ophthalmol. 1996 Jul; 114(7):809-14.
      View in: PubMed
    182. Wu AW, Coleson LC, Holbrook J, Jabs DA. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. Arch Ophthalmol. 1996 Jul; 114(7):841-7.
      View in: PubMed
    183. Jabs DA. Acquired immunodeficiency syndrome and the eye--1996. Arch Ophthalmol. 1996 Jul; 114(7):863-6.
      View in: PubMed
    184. Jabs DA, Lee B, Burek CL, Saboori AM, Prendergast RA. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1996 Feb; 37(2):377-83.
      View in: PubMed
    185. Jabs DA, Burns WH, Prendergast RA. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1996 Jan; 37(1):246-50.
      View in: PubMed
    186. Jabs DA. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial. Antiviral Res. 1996 Jan; 29(1):69-71.
      View in: PubMed
    187. Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996 Jan; 121(1):47-56.
      View in: PubMed
    188. Tay-Kearney ML, Jabs DA. Treatment of CMV retinopathy in patients with AIDS. Ocul Immunol Inflamm. 1996; 4(2):113-8.
      View in: PubMed
    189. Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995 Sep 7; 333(10):670.
      View in: PubMed
    190. Jabs DA. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Infect Agents Dis. 1995 Sep; 4(3):131-42.
      View in: PubMed
    191. Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 1995 May; 119(5):587-96.
      View in: PubMed
    192. Fekrat S, Dunn JP, Lee D, Miller T, Jabs DA. Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. Arch Ophthalmol. 1995 Jan; 113(1):18.
      View in: PubMed
    193. Dunn JP, Jabs DA. Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment. AIDS Clin Rev. 1995-1996; 99-129.
      View in: PubMed
    194. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995; 93:623-83.
      View in: PubMed
    195. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol. 1994 Dec; 130(12):1521-9.
      View in: PubMed
    196. Jabs DA, Kuppers RC, Saboori AM, Burek CL, Enger C, Lee B, Prendergast RA. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol. 1994 Mar; 154(1):66-76.
      View in: PubMed
    197. Elkins BS, Holland GN, Opremcak EM, Dunn JP, Jabs DA, Johnston WH, Green WR. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994 Mar; 101(3):499-507.
      View in: PubMed
    198. Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB, Santos GW. The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol. 1994 Mar; 112(3):372-9.
      View in: PubMed
    199. Lim JI, Enger C, Haller JA, Campochiaro PA, Meredith TA, de Bustros S, Dunn JP, Jabs DA. Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology. 1994 Feb; 101(2):264-9.
      View in: PubMed
    200. Jabs DA, Prendergast RA. Murine models of Sjögren's syndrome. Adv Exp Med Biol. 1994; 350:623-30.
      View in: PubMed
    201. Dunn JP, Jabs DA, Wingard J, Enger C, Vogelsang G, Santos G. Bone marrow transplantation and cataract development. Arch Ophthalmol. 1993 Oct; 111(10):1367-73.
      View in: PubMed
    202. Dunn JP, Jabs DA. Ocular microvasculopathy after bone marrow transplantation. Ann Intern Med. 1992 Jun 1; 116(11):956-7.
      View in: PubMed
    203. Jabs DA, Burek CL, Hu Q, Kuppers RC, Lee B, Prendergast RA. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol. 1992 May; 141(2):496-507.
      View in: PubMed
    204. Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE, Jabs DA, Corio RL, Levin LS, Colvin OM, Wingard JR, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med. 1992 Apr 16; 326(16):1055-8.
      View in: PubMed
    205. Jabs DA. Treatment of cytomegalovirus retinitis--1992. Arch Ophthalmol. 1992 Feb; 110(2):185-7.
      View in: PubMed
    206. Palay DA, Sternberg P, Davis J, Lewis H, Holland GN, Mieler WF, Jabs DA, Drews C. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol. 1991 Sep 15; 112(3):250-5.
      View in: PubMed
    207. Jabs DA, Prendergast RA. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody. Invest Ophthalmol Vis Sci. 1991 Sep; 32(10):2718-22.
      View in: PubMed
    208. Avery R, Jabs DA, Wingard JR, Vogelsang G, Saral R, Santos G. Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. Ophthalmology. 1991 Aug; 98(8):1294-301.
      View in: PubMed
    209. Jabs DA, Enger C, Haller J, de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991 Jun; 109(6):794-9.
      View in: PubMed
    210. Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 1991 May 15; 111(5):601-10.
      View in: PubMed
    211. Jabs DA, Prendergast RA. Ocular inflammation in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1991 May; 32(6):1944-7.
      View in: PubMed
    212. Jabs DA, Enger C, Prendergast RA. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci. 1991 Feb; 32(2):371-80.
      View in: PubMed
    213. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H, Mutasim D, Ariss-Abdo L, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990 Dec 20; 323(25):1729-35.
      View in: PubMed
    214. Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990 Feb 15; 109(2):168-73.
      View in: PubMed
    215. Jabs DA. Ocular toxoplasmosis. Int Ophthalmol Clin. 1990; 30(4):264-70.
      View in: PubMed
    216. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS, Beschorner WE, Cahill RA, Miller DF, Harrison D, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood. 1989 Sep; 74(4):1428-35.
      View in: PubMed
    217. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol. 1989 Sep; 107(9):1343-8.
      View in: PubMed
    218. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989 Jul; 96(7):1092-9.
      View in: PubMed
    219. Ahearn JM, Calomiris JJ, Wigley FM, Jabs DA, Bias WB, Hochberg MC. Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease association. Arthritis Rheum. 1989 Jul; 32(7):870-6.
      View in: PubMed
    220. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology. 1989 Jun; 96(6):896-904.
      View in: PubMed
    221. Guyer DR, Jabs DA, Brant AM, Beschorner WE, Green WR. Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation. Arch Ophthalmol. 1989 Jun; 107(6):868-74.
      View in: PubMed
    222. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jan; 107(1):75-80.
      View in: PubMed
    223. Jabs DA, Prendergast RA. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. Invest Ophthalmol Vis Sci. 1988 Sep; 29(9):1437-43.
      View in: PubMed
    224. Schachat AP, Jabs DA, Graham ML, Ambinder RF, Green WR, Saral R. Leukemic iris infiltration. J Pediatr Ophthalmol Strabismus. 1988 May-Jun; 25(3):135-8.
      View in: PubMed
    225. Jabs DA, Hanneken AM, Schachat AP, Fine SL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol. 1988 Feb; 106(2):230-4.
      View in: PubMed
    226. Jabs DA, Prendergast RA. Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med. 1987 Oct 1; 166(4):1198-203.
      View in: PubMed
    227. Jabs DA, Newman C, De Bustros S, Polk BF. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987 Jul; 94(7):824-30.
      View in: PubMed
    228. Anhalt GJ, Jampel HD, Patel HP, Diaz LA, Jabs DA, Mutasim DF. Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomes. Invest Ophthalmol Vis Sci. 1987 May; 28(5):903-7.
      View in: PubMed
    229. Jabs DA, Schachat AP, Liss R, Knox DL, Michels RG. Presumed varicella zoster retinitis in immunocompromised patients. Retina. 1987; 7(1):9-13.
      View in: PubMed
    230. Jabs DA, Wingard JR, de Bustros S, de Miranda P, Saral R, Santos GW. BW B759U for cytomegalovirus retinitis: intraocular drug penetration. Arch Ophthalmol. 1986 Oct; 104(10):1436-7.
      View in: PubMed
    231. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986 Sep 15; 102(3):297-301.
      View in: PubMed
    232. Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol. 1986 Apr; 104(4):564-8.
      View in: PubMed
    233. Jabs DA, Arnett FC, Bias WB, Beale MG. Familial abnormalities of lymphocyte function in a large Sjögren's syndrome kindred. J Rheumatol. 1986 Apr; 13(2):320-6.
      View in: PubMed
    234. Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol. 1986 Apr; 104(4):558-63.
      View in: PubMed
    235. Jabs DA, Alexander EL, Green WR. Ocular inflammation in autoimmune MRL/Mp mice. Invest Ophthalmol Vis Sci. 1985 Sep; 26(9):1223-9.
      View in: PubMed
    236. Jabs DA, Houk JL, Bias WB, Arnett FC. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985 May; 78(5):801-4.
      View in: PubMed
    237. Newsome DA, Green WR, Miller ED, Kiessling LA, Morgan B, Jabs DA, Polk BF. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol. 1984 Nov; 98(5):590-601.
      View in: PubMed
    238. Hirst LW, Jabs DA, Stoskopf M, Strandberg JD, Kempski S. Benign epibulbar melanocytoma in a horse. J Am Vet Med Assoc. 1983 Aug 1; 183(3):333-4.
      View in: PubMed
    239. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983 Apr; 101(4):580-4.
      View in: PubMed
    240. Jabs DA, Hirst LW, Green WR, Tutschka PJ, Santos GW, Beschorner WE. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol. 1983 Apr; 101(4):585-90.
      View in: PubMed
    241. Jabs DA, Miller NR, Green WR. Ischaemic optic neuropathy with painful ophthalmoplegia in diabetes mellitus. Br J Ophthalmol. 1981 Oct; 65(10):673-8.
      View in: PubMed
    242. Loren A, Charman D, Jabs D, Yokoyama MM. Determination of homozygote vs heterozygote of blood group antigens with protein A. Kurume Med J. 1980; 27(2):71-7.
      View in: PubMed
    Jabs's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067